Dolezal, KA; Besirli, CG; Mian, SI; Sugar, A; Moroi, SE; Bohnsack, BL. Glaucoma and Cornea Surgery Outcomes in Peters Anomaly. American Journal of Ophthalmology. 2019; 208:367-375.

Buhr, ED; Vemaraju, S; Diaz, N; Lang, RA; Van Gelder, RN. Neuropsin (OPN5) Mediates Local Light-Dependent Induction of Circadian Clock Genes and Circadian Photoentrainment in Exposed Murine Skin. Current Biology. 2019; 29(20):3478-3487.e4.

Utz, VM; Bulas, S; Lopper, S; Fenchel, M; Sa, T; Mehta, M; Ash, D; Lovell, DJ; Kaufman, AH. Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis. Pediatric Rheumatology Online Journal. 2019; 17(1).

Binenbaum, G; Tomlinson, LA; De Alba Campomanes, AG; Bell, EF; Donohue, P; Morrison, D; Quinn, GE; Repka, MX; Rogers, D; Yang, MB; Yu, Y; Ying, GS. Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria. JAMA Ophthalmology. 2020; 138(1):31-37.

Wallace, DK; Kraker, RT; Freedman, SF; Crouch, ER; Bhatt, AR; Hartnett, ME; Yang, MB; Rogers, DL; Hutchinson, AK; Vanderveen, DK; Haider, KM; Siatkowski, RM; Dean, TW; Beck, RW; Repka, MX; Smith, LE; Good, WV; Kong, L; Cotter, SA; Holmes, JM. Short-term Outcomes after Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity. JAMA Ophthalmology. 2020; 138(6):698-698.